Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer.

Kuhar, Cvetka Grasic; Borstnar, Simona; Gazic, Barbara; Matos, Erika

Kuhar, Cvetka Grasic; Borstnar, Simona; Gazic, Barbara; Matos, Erika.

Affiliation

Kuhar CG; Institute of Oncology Ljubljana, Department of Medical Oncology, Zaloska 2, 1000, Ljubljana, Slovenia; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.
Borstnar S; Institute of Oncology Ljubljana, Department of Medical Oncology, Zaloska 2, 1000, Ljubljana, Slovenia; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.
Gazic B; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia; Institute of Oncology Ljubljana, Department of Pathology, Zaloska 2, 1000, Ljubljana, Slovenia.
Matos E; Institute of Oncology Ljubljana, Department of Medical Oncology, Zaloska 2, 1000, Ljubljana, Slovenia; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia. Electronic address: ematos@onko-i.si.

Breast ; 69: 481-490, 2023 Jun.

Article in En | MEDLINE | ID: mdl-36740512

Subject(s)

Breast Neoplasms; Inflammatory Breast Neoplasms; Humans; Female; Inflammatory Breast Neoplasms/therapy; Breast Neoplasms/pathology; Prognosis; Treatment Outcome; Retrospective Studies; Axilla/pathology; Chemotherapy, Adjuvant; Neoadjuvant Therapy; Receptor, ErbB-2

Key words

Immunohistochemistry-based subtype; Inflammatory breast cancer; Pathologic complete response; Prognostic factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Inflammatory Breast Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans Language: En Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google